UNII 55X04QC32I

SODIUM HYDROXIDE

Unique Ingredient Identifier 55X04QC32I is listed as a ingredient substance
RN1310-73-2
EC215-185-5
NCITC74373
RXCUI9880
PUBCHEM14798
MFNa.HO
INCHI KEYHEMHJVSKTPXQMS-UHFFFAOYSA-M
SMILES[OH-].[Na+]

Alternate Names

Dosage Forms

UNII 55X04QC32I SODIUM HYDROXIDE is commonly included in medications in the following forms.

RouteDosage FormPotency
AN,CNBLK INTRATHECALINJECTION ADJPH
AN,INFILTRATIONINJECTABLE ADJPH
AN,INFILTRATIONINJECTION0.071 %
AN,INFILTRATIONSOLUTION, INJECTION ADJPH
AN,SYMPATHETIC NBLKINJECTION ADJPH
AURICULAR (OTIC)SOLUTION0.8 %
AURICULAR (OTIC)SOLUTION, DROPS ADJPH
AURICULAR (OTIC)SUSPENSION ADJPH
BUCCALFILM0.09 MG
BUCCALFILM, SOLUBLE1.18 MG
CAUDAL BLOCKINJECTABLE ADJPH
CAUDAL BLOCKINJECTION ADJPH
DENTALINJECTABLE ADJPH
DENTALINJECTION ADJPH
DENTALPASTE NA
DENTALSOLUTION ADJPH
EPIDURALINJECTION ADJPH
EPIDURALINJECTION, SOLUTION ADJ PH
EPIDURALLIQUID, WATER, STERILE, FOR INJECTION ADJPH
EPIDURALSOLUTION ADJPH
EPIDURALSOLUTION, INJECTION ADJPH
EXTRACORPOREALINJECTION ADJPH
EXTRACORPOREALSOLUTION ADJPH
IM - IVINJECTABLE ADJPH
IM - IVINJECTION4.2 mg/mL
IM - IVINJECTION ADJ PH
IM - IVINJECTION ADJPH
IM - IVINJECTION, SOLUTION ADJPH
IM - IVLIQUID, WATER, STERILE, FOR INJECTION ADJPH
IM - IVPOWDER ADJPH
IM - IVPOWDER, FOR INJECTION SOLUTION0.7 %
IM - IVPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED ADJPH
IM - IVSOLUTION, INJECTION0.13 %
IM - IV - SCINJECTION ADJPH
IM - IV - SCPOWDER, FOR INJECTION SOLUTION ADJPH
IM - IV - SCPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED ADJPH
IM - IV - SCSOLUTION, INJECTION ADJPH
IM - SCINJECTION ADJPH
IM - SCINJECTION, SUSTAINED ACTION ADJPH
IM - SCPOWDER, FOR INJECTION SOLUTION ADJPH
IM, IVINJECTION ADJ PH
INFILTRATIONINJECTION ADJPH
INFILTRATIONINJECTION, SOLUTION ADJ PH
INFILTRATIONSOLUTION, INJECTION ADJPH
INHALATIONAEROSOL, METERED ADJPH
INHALATIONINHALANT SOLUTION DOSAGE FORM ADJ PH
INHALATIONSOLUTION8 %
INHALATIONSOLUTION ADJ PH
INJECTIONINJECTABLE ADJ PH
INJECTIONINJECTION ADJ PH
INJECTIONINJECTION, SOLUTION ADJ PH
INTERSTITIALINJECTION ADJPH
INTRA-AMNIOTICINJECTION ADJPH
INTRA-ARTERIALINJECTABLE0.44 %
INTRA-ARTERIALINJECTION17.6 %
INTRA-ARTERIALINJECTION4.2 mg/mL
INTRA-ARTERIALPOWDER, FOR INJECTION SOLUTION ADJPH
INTRA-ARTERIALPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED ADJPH
INTRA-ARTERIALSOLUTION, INJECTION ADJPH
INTRA-ARTERIALSUSPENSION, INJECTION ADJ PH
INTRA-ARTICULARINJECTABLE ADJPH
INTRA-ARTICULARINJECTION ADJ PH
INTRA-ARTICULARINJECTION ADJPH
INTRA-ARTICULARINJECTION, SOLUTION ADJ PH
INTRA-ARTICULARINJECTION, SUSTAINED ACTION ADJPH
INTRABURSALINJECTION ADJPH
INTRACARDIACINJECTION ADJPH
INTRACAUDALINJECTION ADJPH
INTRACAUDALINJECTION, SOLUTION ADJ PH
INTRACAVITARYINJECTION ADJPH
INTRACAVITARYPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED ADJPH
INTRADERMALINJECTION ADJPH
INTRADERMALINJECTION, SUSTAINED ACTION ADJPH
INTRADERMALPOWDER, FOR INJECTION SOLUTION ADJPH
INTRADISCALPOWDER, FOR INJECTION SOLUTION ADJPH
INTRALESIONALINJECTABLE ADJPH
INTRALESIONALINJECTION ADJPH
INTRALESIONALINJECTION, SUSTAINED ACTION ADJPH
INTRALESIONALSUSPENSION, INJECTION ADJPH
INTRAMUSCULARINJECTABLE0.44 %W/V
INTRAMUSCULARINJECTABLE ADJ PH
INTRAMUSCULARINJECTION17.6 %
INTRAMUSCULARINJECTION4.2 mg/mL
INTRAMUSCULARINJECTION ADJ PH
INTRAMUSCULARINJECTION, SOLUTION ADJ PH
INTRAMUSCULARINJECTION, SOLUTION ADJPH
INTRAMUSCULARINJECTION, SUSPENSION ADJ PH
INTRAMUSCULARINJECTION, SUSTAINED ACTION ADJPH
INTRAMUSCULARLIQUID ADJPH
INTRAMUSCULARPOWDER, FOR INJECTION SOLUTION ADJPH
INTRAMUSCULARPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED0.35 %W/V
INTRAMUSCULARSOLUTION ADJPH
INTRAMUSCULARSOLUTION, INJECTION0.1 %W/V
INTRAMUSCULARSUSPENSION, EXTENDED RELEASE ADJPH
INTRAMUSCULARSUSPENSION, INJECTION0.43 %
INTRAOCULARSOLUTION ADJPH
INTRAPERITONEALINJECTION ADJPH
INTRAPERITONEALSOLUTION ADJPH
INTRAPLEURALINJECTION ADJPH
INTRASPINALINJECTION ADJPH
INTRASYNOVIALINJECTABLE ADJPH
INTRASYNOVIALINJECTION ADJPH
INTRASYNOVIALINJECTION, SUSTAINED ACTION ADJPH
INTRASYNOVIALSUSPENSION, INJECTION ADJPH
INTRATHECALINJECTABLE0.44 %
INTRATHECALINJECTION17.6 %
INTRATHECALINJECTION4.2 mg/mL
INTRATHECALINJECTION, SOLUTION ADJ PH
INTRATHECALPOWDER, FOR INJECTION SOLUTION ADJPH
INTRATHECALPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED ADJPH
INTRATHECALSOLUTION ADJPH
INTRATHECALSOLUTION, INJECTION ADJPH
INTRATRACHEALINJECTION NA
INTRATRACHEALPOWDER, FOR SUSPENSION ADJPH
INTRATRACHEALSUSPENSION ADJPH
INTRATUMORINJECTABLE ADJPH
INTRATUMORINJECTION ADJPH
INTRATUMORPOWDER, FOR INJECTION SOLUTION ADJPH
INTRAUTERINEINJECTION ADJPH
INTRAVASCULARINJECTION ADJPH
INTRAVASCULARSOLUTION ADJPH
INTRAVASCULARSOLUTION, INJECTION ADJPH
INTRAVENOUSEMULSION, INJECTION ADJ PH
INTRAVENOUSEMULSION, INJECTION ADJPH
INTRAVENOUSINJECTABLE0.6 %
INTRAVENOUSINJECTABLE ADJ PH
INTRAVENOUSINJECTION11.6 MG/VIAL
INTRAVENOUSINJECTION9.6 %
INTRAVENOUSINJECTION4.2 mg/40mL
INTRAVENOUSINJECTION0.64 MG/1ML
INTRAVENOUSINJECTION ADJ PH
INTRAVENOUSINJECTION ADH PH
INTRAVENOUSINJECTION QS
INTRAVENOUSINJECTION ADJPH
INTRAVENOUSINJECTION, EMULSION ADJ PH
INTRAVENOUSINJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSP ADJPH
INTRAVENOUSINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION ADJPH
INTRAVENOUSINJECTION, SOLUTION1.2 mg/1mL
INTRAVENOUSINJECTION, SOLUTION ADJ PH
INTRAVENOUSINJECTION, SOLUTION QS
INTRAVENOUSINJECTION, SOLUTION ADJPH
INTRAVENOUSINJECTION, SUSPENSION ADJPH
INTRAVENOUSINJECTION, SUSPENSION, LIPOSOMAL ADJPH
INTRAVENOUSLIQUID ADJPH
INTRAVENOUSLIQUID ADJ PH
INTRAVENOUSLIQUID, WATER, STERILE, FOR INJECTION ADJPH
INTRAVENOUSPOWDER ADJPH
INTRAVENOUSPOWDER FOR INJECTION DOSAGE FORM ADJ PH
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION22 mg/1VIAL
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION13.66 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION ADJ PH
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED78.36 MG/1VIAL
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED19.27 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED11.6 MG/VIAL
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED ADJ PH
INTRAVENOUSSOLUTION ADJ PH
INTRAVENOUSSOLUTION ADJPH
INTRAVENOUSSOLUTION, CONCENTRATE ADJPH
INTRAVENOUSSOLUTION, INJECTION0.1 %
INTRAVENOUSSOLUTION, LIPOSOME, INJECTION ADJPH
INTRAVENOUSSOLUTION, LIQUID ADJ PH
INTRAVENOUS INFUSIONINJECTABLE ADJ PH
INTRAVENOUS INFUSIONINJECTION0.12 %
INTRAVENOUS INFUSIONINJECTION ADJ PH
INTRAVENOUS INFUSIONPOWDER ADJ PH
INTRAVESICALSOLUTION, INJECTION ADJPH
INTRAVITREALINJECTABLE ADJPH
INTRAVITREALINJECTION ADJPH
INTRAVITREALSUSPENSION, INJECTION ADJPH
IONTOPHORESISDRUG DELIVERY SYSTEM4.2 MG
IONTOPHORESISSOLUTION ADJPH
IRRIGATIONSOLUTION ADJPH
IRRIGATIONSOLUTION, IRRIGATION ADJPH
IV - SCINJECTION ADJPH
IV - SCPOWDER, FOR INJECTION SOLUTION ADJPH
IV - SCSOLUTION, INJECTION ADJPH
IV(INFUSION)EMULSION, INJECTION ADJPH
IV(INFUSION)INFUSION ADJPH
IV(INFUSION)INJECTABLE ADJPH
IV(INFUSION)INJECTION ADJPH
IV(INFUSION)INJECTION, LIPOSOMAL ADJPH
IV(INFUSION)LIQUID, WATER, STERILE, FOR INJECTION ADJPH
IV(INFUSION)POWDER, FOR INJECTION SOLUTION9 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION, LYOPHILIZED1.57 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION, LYOPHILIZED ADJ PH
IV(INFUSION)SOLUTION2.78 %
IV(INFUSION)SOLUTION, INJECTION2.83 %
NASALSOLUTION ADJPH
NASALSOLUTION, FOR INHALATION ADJPH
NASALSOLUTION, SPRAY ADJPH
NASALSPRAY ADJPH
NASALSPRAY, METERED0.004 %
NERVE BLOCKINJECTABLE ADJPH
NERVE BLOCKINJECTION0.071 %
NERVE BLOCKSOLUTION, INJECTION ADJPH
OPHTHALMICDROPS NA
OPHTHALMICEMULSION0.4 %W/W
OPHTHALMICEMULSION ADJ PH
OPHTHALMICGEL1.69 %
OPHTHALMICPOWDER, FOR SOLUTION ADJPH
OPHTHALMICSOLUTION0.59 %
OPHTHALMICSOLUTION0.53 MG/1ML
OPHTHALMICSOLUTION ADJ PH
OPHTHALMICSOLUTION, DROPS0.1 %
OPHTHALMICSOLUTION, DROPS ADJ PH
OPHTHALMICSOLUTION, IRRIGATION ADJPH
OPHTHALMICSOLUTION/ DROPS ADJ PH
OPHTHALMICSOLUTION/DROPS ADJPH
OPHTHALMICSUSPENSION ADJPH
OPHTHALMICSUSPENSION, DROPS ADJPH
ORALCAPSULE9.88 MG
ORALCAPSULE ADJ PH
ORALCAPSULE, COATED0.08 MG
ORALCAPSULE, COATED PELLETS0.013 MG
ORALCAPSULE, DELAYED ACTION0.25 MG
ORALCAPSULE, ENTERIC COATED PELLETS0.083 MG
ORALCAPSULE, SOFT GELATIN LIQUID-FILLED1.5 MG
ORALCONCENTRATE10 MG/5ML
ORALEMULSION ADJPH
ORALFILM, SOLUBLE1.84 MG
ORALGRANULE, FOR ORAL SUSPENSION ADJPH
ORALLIQUID2 MG/5ML
ORALLIQUID ADJ PH
ORALPOWDER, FOR ORAL SUSPENSION1.7 MG/50ML
ORALPOWDER, FOR SOLUTION ADJPH
ORALSOLUTION80 MG/1ML
ORALSOLUTION4.56 G/160 mL
ORALSOLUTION4.5 MG/5ML
ORALSOLUTION, ELIXIR ADJPH
ORALSOLUTION, INJECTION ADJPH
ORALSUSPENSION8 %
ORALSYRUP71 MG/5ML
ORALTABLET7 MG
ORALTABLET, COATED NA
ORALTABLET, DELAYED ACTION1.24 MG
ORALTABLET, DELAYED ACTION, ENTERIC COATED0.32 MG
ORALTABLET, DELAYED RELEASE0.1 MG
ORALTABLET, EXTENDED RELEASE5.33 MG
ORALTABLET, ORALLY DISINTEGRATING0.16 MG
ORALTABLET, SUSTAINED ACTION0.4 MG
OTICSUSPENSION ADJPH
PARENTERALINJECTION ADJPH
PARENTERALLIQUID, WATER, STERILE, FOR INJECTION ADJPH
PARENTERALPOWDER, FOR INJECTION SOLUTION ADJPH
PERFUSION, CARDIACSOLUTION ADJPH
PERIDURALINJECTION ADJPH
PERINEURALINJECTION ADJPH
PHOTOPHERESISSOLUTION ADJPH
RECTALENEMA0.44 %
RECTALPOWDER, FOR INJECTION SOLUTION ADJPH
RECTALSOLUTION0.63 %
RESPIRATORY (INHALATION)POWDER, FOR INHALATION ADJPH
RESPIRATORY (INHALATION)SOLUTION ADJPH
RESPIRATORY (INHALATION)SOLUTION, AEROSOL, FOR INHALATION ADJPH
RESPIRATORY (INHALATION)SOLUTION, FOR INHALATION0.058 %
RESPIRATORY (INHALATION)SOLUTION, INJECTION ADJPH
RETROBULBARINJECTION ADJPH
SOFT TISSUEINJECTABLE ADJPH
SOFT TISSUEINJECTION ADJPH
SOFT TISSUEINJECTION, SUSTAINED ACTION ADJPH
SOFT TISSUESUSPENSION, INJECTION ADJPH
SPINALINJECTABLE ADJPH
SPINALINJECTION ADJPH
SUBARACHNOIDSOLUTION, INJECTION ADJPH
SUBCONJUNCTIVALINJECTION ADJPH
SUBCUTANEOUSINJECTABLE0.42 %
SUBCUTANEOUSINJECTION3.15 %
SUBCUTANEOUSINJECTION ADJ PH
SUBCUTANEOUSINJECTION, SOLUTION ADJ PH
SUBCUTANEOUSINJECTION, SOLUTION ADJPH
SUBCUTANEOUSPOWDER, FOR INJECTION SOLUTION ADJPH
SUBCUTANEOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED ADJPH
SUBCUTANEOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADJPH
SUBCUTANEOUSSOLUTION ADJ PH
SUBCUTANEOUSSOLUTION, INJECTION1 %
SUBCUTANEOUSSUSPENSION ADJPH
SUBCUTANEOUSSUSPENSION, INJECTION0.073 %
SUBMUCOSALINJECTION ADJPH
SUBMUCOSALSOLUTION, INJECTION ADJPH
TOPICALCREAM0.55 %W/W
TOPICALCREAM, AUGMENTED2.72 %W/V
TOPICALCREAM, EMULSION, SUSTAINED RELEASE2.72 %W/V
TOPICALDISC NA
TOPICALEMULSION0.2 %W/W
TOPICALEMULSION, AEROSOL FOAM ADJPH
TOPICALEMULSION, CREAM0.52 %W/W
TOPICALEMULSION, CREAM ADJ PH
TOPICALEMULSION, LOTION0.022 %W/W
TOPICALGEL3.2 %W/W
TOPICALGEL0.0684 ADJ PH
TOPICALJELLY NA
TOPICALLOTION2.6 %W/W
TOPICALLOTION ADJ PH
TOPICALLOTION, AUGMENTED NA
TOPICALOINTMENT NA
TOPICALOINTMENT, AUGMENTED0.11 %W/W
TOPICALSHAMPOO NA
TOPICALSOLUTION0.59 %W/V
TOPICALSOLUTION0.002 MG/1ML
TOPICALSOLUTION ADJ PH
TOPICALSOLUTION, DROPS ADJPH
TOPICALSOLUTION/DROPS NA
TOPICALSPONGE NA
TOPICALSUSPENSION NA
TOPICALSUSPENSION, DROPS NA
TOPICALSWAB ADJPH
TRANSDERMALDRUG DELIVERY SYSTEM4.2 MG
TRANSDERMALFILM, CONTROLLED RELEASE0.85 MG
TRANSDERMALGEL4.72 %
TRANSDERMALGEL ADJ PH
TRANSDERMALGEL, METERED7 %
URETERALSOLUTION ADJPH
URETHRALSOLUTION ADJPH
VAGINALCREAM, EMULSION, SUSTAINED RELEASE0.025 %
VAGINALEMULSION, CREAM0.19 %
VAGINALGEL0.25 %

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.